“We are pleased that our balance sheet and cash flow enable us to return value to our shareholders through share repurchases as we continue to invest in internal and external opportunities," said Norman Schwartz, Bio-Rad President and CEO. “Earlier this year we discussed our capital allocation approach and a share repurchase program is part of this strategy.”
Repurchases may be made at management's discretion from time to time on the open market or through privately negotiated transactions. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Any shares acquired will be available for general corporate purposes, including supporting employee stock plans, funding acquisitions and minimizing dilution from stock issuances. This new share repurchase program supersedes the Company’s prior share repurchase program.
Contacts
Bio-Rad Laboratories, Inc.
Tina Cuccia
Corporate Communications
Tel: +1 510-724-7000
Email: tina_cuccia@bio-rad.com
